EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
91 hedge funds and large institutions have $275M invested in Eiger BioPharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
8% more funds holding
Funds holding: 84 → 91 (+7)
Holders
91
Holding in Top 10
6
Calls
$290K
Puts
$182K
Top Buyers
| 1 | +$3.79M | |
| 2 | +$1.61M | |
| 3 | +$1.31M | |
| 4 |
Two Sigma Investments
New York
|
+$1.11M |
| 5 |
Two Sigma Advisers
New York
|
+$810K |
Top Sellers
| 1 | -$9.1M | |
| 2 | -$5.9M | |
| 3 | -$2.45M | |
| 4 |
BC
Broadfin Capital
New York
|
-$1.95M |
| 5 |
TI
Telemetry Investments
New York
|
-$1.21M |